Experts: Apple Disclosure 'Falls Short'

Apple's handling of reports that CEO Steve Jobs had a liver transplant has rekindled concern among corporate governance experts that the company and its board are disclosing too little, too late on the health of its highest-ranking executive.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.